Deborah Autor, a deputy FDA commissioner, told the committee the agency currently has limited ability to conduct regular inspections of foreign suppliers or to block suspected drugs.
Committee members referred to a 2007 case when adulterated heparin reached the U.S. market from China.
Related Articles on Problems With Drug Shipments:
Senator Proposes System to Avert Drug Shortages, Improve Safety
Drug Shortages Spur Price Gouging, With Markups Averaging 650%
5 Updates on the Nationwide Drug Shortage
